VEEV
Veeva Systems
Health Care · Health Care Technology · US

$166.34
Close 2026-01-31
✗ ETHICAL FAIL

MODERATE MOAT

HIGH
Data Confidence: 100%
Full financial profile available

Market Cap
$27.1B
Trailing P/E
30.60
Forward P/E
16.80
Rev Growth
+16.0%
Profit Margin
28.4%
ROE
13.9%
Analyst Target
$264.46
Recommendation
BUY

About Veeva Systems

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides Veeva Data Cloud, such as Veeva OpenData, a customer reference data solution; Veeva Link, which provides deep data; Veeva Compass, which includes de-identified and longitudinal patient data; and Veeva CRM Pulse that provides access and multichannel engagement metrics. In addition, the company offers Veeva Development Cloud consisting of Veeva Clinical Platform, which advances clinical trial execution; Veeva Clinical Data Management that helps sponsors and CROs design and run trials; Veeva Safety, which unifies systems and processes; Veeva RIM that provides regulatory information management capabilities, as well as Veeva Quality Cloud, which is used by the life sciences and consumer products industries; and Veeva Business Consulting services. Further, it provides professional and support services, including implementation and deployment planning, and project management; requirements analysis, solution design, and configuration; systems environment management and deployment; services focused on advancing or transforming business and operating processes; technical consulting services on data migration and systems integrations; training; and ongoing managed services, such as outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.

Opportunity Summary
Trading at $166 against a fair value of $247, a 33% discount. Moderate competitive position. Fails ethical screen (Interest-bearing securities). Ranks better than 41% of screened stocks.

Ethical Screen
Business Activity PASS
Debt Ratio (0.01%) PASS
Cash Ratio (0.57%) FAIL
Receivables Ratio (0.30%) PASS
Revenue Ratio (0.08%) FAIL
Overall FAIL
Score Ethical: 10.0
Score Valuation: 77.5
Score Quality: 46.0
Score Combined: 43.4
Fair Value Est: $247.00 · Margin of Safety: +48.5% · Tier: AVOID

Full Analysis

Opportunity scores, earnings history, insider transactions, institutional holders, analyst consensus, and more.

Unlock with Membership

Opportunity Scores
Valuation87.3
Quality50.6
Cash Flow48.8
Moat50.0
Balance Sheet100.0
Debt Purity96.8
Liquid Purity0.0
Rev Purity0.0
Compliance39.8
Tier: GOLD · Score: 73.0 · Rank: #212

Earnings History (Last 8 Quarters)
Date EPS Est. Reported EPS Surprise %
2026-06-03 2.14 Pending
2026-03-04 1.94 2.06 +6.5%
2025-11-20 1.95 2.04 +4.5%
2025-08-27 1.90 1.99 +4.8%
2025-05-28 1.74 1.97 +13.0%
2025-03-05 1.58 1.74 +10.1%
2024-12-05 1.58 1.75 +10.7%
2024-08-28 1.53 1.62 +5.6%

Quarterly Financials
Period Revenue Net Income EBITDA Gross Profit Op. Income EPS
2026-01-31 $836.0M $244.2M $254.2M $622.5M $245.9M 1.49
2025-10-31 $811.2M $236.2M $250.6M $611.8M $240.9M 1.44
2025-07-31 $789.1M $200.3M $206.0M $593.8M $195.9M 1.23
2025-04-30 $759.0M $228.2M $243.6M $585.2M $233.7M 1.40
2025-01-31 $720.9M $195.6M $198.4M $539.9M $188.4M 1.20
2024-10-31

Insider Transactions
Date Name Role Shares Value
2026-04-30 HUNG PRISCILLA C Director 750 $116.7K
2026-04-10 HUNG PRISCILLA C Director 750 $115.1K
2026-04-01 VAN WAGENER BRIAN Chief Financial Officer 872
2026-04-01 KONDATH VIPIN Officer 2,603
2026-04-01 SCHWENGER THOMAS D President 2,043
2026-04-01 ZUPPAS ELENI NITSA A President 8,998
2026-04-01 FADDIS JONATHAN W General Counsel 8,726
2026-03-05 SCHWENGER THOMAS D President 1,000 $200.0K
2026-02-27 RITTER GORDON Director 297
2026-02-27 HUNG PRISCILLA C Director 262
Top Institutional Holders
Holder Shares Value % Held
Blackrock Inc. 11.6M $1.9B 0.1%
Vanguard Portfolio Management LLC 7.4M $1.2B 0.0%
Vanguard Capital Management LLC 6.7M $1.1B 0.0%
Alliancebernstein L.P. 6.3M $1.0B 0.0%
Linonia Partnership LP 4.9M $788.8M 0.0%
Principal Financial Group, Inc. 4.1M $663.4M 0.0%
State Street Corporation 3.6M $578.0M 0.0%
T. Rowe Price Investment Management, Inc. 3.4M $545.5M 0.0%
Geode Capital Management, LLC 3.3M $530.6M 0.0%
FMR, LLC 2.6M $418.6M 0.0%

Analyst Recommendations
3 Months Ago
8
14
7
30 analysts

2 Months Ago
9
14
8
32 analysts

Last Month
9
15
8
33 analysts

Current
8
14
7
30 analysts

Strong Buy
Buy
Hold
Sell
Strong Sell

Additional Fundamentals
Enterprise Value
$19.7B
Price/Book
3.64
Beta
0.924
Analysts
28
Total Revenue (TTM)
$3.2B
Total Debt
$95.9M
Earnings Growth
+23.2%
Rec. Mean
1.87
Short Ratio
3.25
Short % Float
0.0%
Employees
7,928

Elite Intelligence

Trade Consideration with position sizing, convergence signals, and risk analysis. Available to Elite members.

Upgrade to Elite

Trade Consideration

The Opportunity
Score 43.4 (P54 — top 46.0% of scored tickers). Moderate Moat. Ethical FAIL. 28 analysts at Buy.
Price: $166.34 | Target: $262.68 (+58%) | Fair Value: $247.00 (+48%)

Score
43

Moat
MODERATE

Conviction
Standard

Upside
+58%

The Fundamentals
Revenue Growth+16.0%
Profit Margin0.0%
ROE13.9%
Forward P/E16.8
Market Cap$27.1B

Earnings Track Record
Date Estimate Reported Surprise
2026-06-03 $2.14 Pending
2026-03-04 $1.94 $2.06 +6.5%
2025-11-20 $1.95 $2.04 +4.5%
2025-08-27 $1.90 $1.99 +4.8%
2025-05-28 $1.74 $1.97 +13.0%
2025-03-05 $1.58 $1.74 +10.1%
Position Sizing Scenarios
Stop: $141.39 (-15%) | Entry: $166.34
Shares Cost Profit to Target R:R
To Consensus ($262.68, 28 analysts)
10 $1,663.40 +$963.40 (58%) 3.9R
50 $8,317.00 +$4,817.00 (58%) 3.9R
100 $16,634.00 +$9,634.00 (58%) 3.9R
To Fair Value ($247.00)
10 $1,663.40 +$806.60 (48%) 3.2R
50 $8,317.00 +$4,033.00 (48%) 3.2R
100 $16,634.00 +$8,066.00 (48%) 3.2R
Risk Factors
  • Elevated short interest (3.25 days to cover)

The Verdict
Veeva Systems holds a moderate competitive moat and trades at a 48.5% discount to fair value.

Quantitative Grade

A single score combining all analytical layers below. A is strongest, D is weakest.

D
Quant Score
32.7
Risk Grade
LOW_RISK
Layers
8
Quality: CONSISTENT_BEATER

Risk Profile

How much could this ticker lose on a bad day? These metrics measure worst-case scenarios from historical data.

VaR 95%
-3.4%
worst expected daily loss, 19 in 20 days
CVaR 95%
-5.0%
avg loss on the worst 5% of days
Annual Volatility
Sortino Ratio
-0.51
above 1.0 is good
Max Drawdown
-50.5%
Worst Day

Forward Outlook

Based on 10,000 simulated price paths, here is the probability of where this ticker could be in 30, 60, and 90 days.

30d Prob Up
90d Prob Up
Median Return 30d
Liquidity Score
90
Liquidity Grade
HIGHLY LIQUID

Trend & Momentum

What direction is this ticker actually moving, filtered through noise? Is it speeding up or slowing down?

Kalman Trend
Trend Strength
Momentum Signal
HMM Regime
RSI Signal

Technical Signals

Classic chart signals that institutional traders monitor. Golden Cross is bullish, Death Cross is bearish.

MA Crossover
BELOW_200
Bollinger Position
LOWER_HALF
Beta
Relative Volume
1.7x
Short Interest

Financial Health

Is this company financially sound? The Z-Score measures bankruptcy risk. The F-Score measures fundamental strength.

Altman Z-Score
below 1.81 = distress zone

Piotroski F-Score

Earnings Beat Rate
100.0%
Earnings Consistency

Correlations

These tickers tend to move together (positive) or in opposite directions (negative). Useful for portfolio diversification.

Most Correlated
Ticker Correlation
DOCU 0.428
WDAY 0.420
FRSH 0.410
BL 0.409
NTSK 0.407
Inverse Correlated
Ticker Correlation
PAVREIT.KL -0.220
NG.L -0.172
MGRT -0.140
SVT.L -0.136
CKISY -0.128

Seasonality

Does this ticker have consistent patterns on certain days or months? Historical tendencies, not guarantees.

Best Day
Friday
Worst Day
Tuesday
Best Month
Jun
Worst Month
Feb
Fri-Mon Effect
0.07022633369628305

Earnings Drift

After this company beats earnings, does the price keep going up? Drift tracks post-earnings momentum.

Avg Drift After Beat
-2.1%
Beat Drift Positive %
37.5%
Consistency

Momentum Rankings

How does this ticker’s recent performance compare to the entire universe? Ranked across 1, 3, 6, and 12-month returns.

1M Return
-1.6%
3M Return
-9.8%
6M Return
-41.4%
12M Return
-32.7%
Momentum Rank
#4035
Momentum Signal
DOWN

Related Tickers

Similar in Healthcare

INCY — Incyte CRMD — CorMedix Inc. ✓ UHS — Universal Health Services ✓ FENC — Fennec Pharmaceuticals Inc. ✓ REGN — Regeneron Pharmaceuticals ✓

Also in TE500

NEM — Newmont ✓ NU — Nu Holdings Ltd. PTC — PTC Inc. ✓ SBNY — Signature Bank EXE — Expand Energy ✓
Discover More
Alpha Insights Market Intelligence Titan Watch Ethical Screener Insider Intelligence Track Record Ethical Finance Zakat Calculator Iran Oil Tracker Foundry Indicators Options Calendar Composites Boycott Tracker Convergence Screener Fed Tracker Explore All Is It Halal? Earnings Calendar Dividend Screener Country Guides Glossary Join Free →

Get our weekly market brief free.